改变了免疫共抑制受体表达和LAG-3表达与NMOSD疾病严重程度的相关性

Nitsan Haham1, Omri Zveik1, Ariel Rechtman1

  • 1Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah- Medical Center, Ein-Kerem, Faculty of Medicine, Hebrew University of Jerusalem, Ein-Karem, Jerusalem 91120, Israel.

PubMed
概括

像TIM-3和LAG-3这样的共抑制受体在神经omyelitis optica光谱障碍 (NMOSD) 中表达的变化. 增加的TIM-3和LAG-3表明LAG-3在NMOSD中的潜在保护作用.

相关概念视频